The use of anti-progesterones as a medical IUD.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Bailliere's clinical obstetrics and gynaecology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 3233821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The progesterone antagonist RU 486. A potential new contraceptive agent

  1988cited by this paper
• Metabolism and serum binding of RU 486 in women after various single doses.

  1987cited by this paper
• Interception. III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women.

  1987cited by this paper
• Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.

  1987cited by this paper
• Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.

  1987cited by this paper
• Uses of RU 486 for contragestion: an update.

  1987cited by this paper
• Interception. IV: Failure of mifepristone (RU 486) as a monthly contragestive, "Lunarette".

  1987cited by this paper
• Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man.

  1987cited by this paper
• Luteal contraception.

  1987cited by this paper
• The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.

  1986cited by this paper
• Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3B-hydroxysteroid dehydrogenase.

  1986cited by this paper
• Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.

  1985cited by this paper
• Effects of an antiprogesterone agent, RU-486, on the menstrual cycle of the rhesus monkey.

  1985cited by this paper
• Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women.

  1985cited by this paper
• Pregnancy prevention by intravaginal delivery of a progesterone antagonist: RU486 tampon for menstrual induction and absorption.

  1985cited by this paper
• RU 486 inhibits peripheral effects of glucocorticoids in humans.

  1985cited by this paper
• The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

  1985cited by this paper
• The new steroid analog RU 486 inhibits glucocorticoid action in man.

  1984cited by this paper
• RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.

  1984cited by this paper

• Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.

  2003cites this paper
• Antiprogestin Action on the Endometrium

  1997cites this paper
• The Pill: Abortifacient or Contraceptive? A Literature Review

  1995cites this paper
• Chapter 15 – Drug treatment

  1991cites this paper